EICHOR
● Recruiting
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
Condition: Breast Cancer · Sponsor: Memorial Sloan Kettering Cancer Center
About this study
The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.
This description comes directly from the study's public registry record.
Talk to the study team
Diana Ng, MD · 212-639-7209 · NgD2@mskcc.org
T. Peter Kingham, MD · 212-639-5260 · kinghamP@mskcc.org
Always discuss trial participation with your own doctor first.
Locations (2)
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York, New York, United States | Recruiting |
| Muhimbili University of Health and Allied Sciences | Dar es Salaam, Tanzania | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05438511